Loading…

Edwards Lifesciences began operations at its initial site in the Shannon Free Zone, Ireland, as part of an €80 million investment plan that will create 600 jobs over several years. The facility will support development and manufacturing of structural heart disease and critical care monitoring products.
“This is an exciting day for the team here at Edwards Lifesciences. Our first day of business represents many years of planning to invest in our global operations to support the development and manufacturing of our patient-focused innovations.”gov.ie
Summarized from public sources; check the original articles before acting on it.